Page last updated: 2024-10-29

nsc 664704 and Cancer of Liver

nsc 664704 has been researched along with Cancer of Liver in 1 studies

kenpaullone: inhibits CDK1/cyclin B; structure in first source
kenpaullone : An indolobenzazepine that is paullone in which the hydrogen at position 9 is replaced by a bromo substituent. It is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3beta (GSK3beta).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, W1
Wu, J1
Dong, H1
Bouck, D1
Zeng, FY1
Chen, T1

Other Studies

1 other study available for nsc 664704 and Cancer of Liver

ArticleYear
Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells.
    The Journal of biological chemistry, 2008, Nov-07, Volume: 283, Issue:45

    Topics: Benzazepines; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase 2; Cytochrome P-450 CYP3A; Enzym

2008